SNDX - Syndax Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$38.50
DETAILS
HIGH:
$46.00
LOW:
$31.00
MEDIAN:
$38.50
CONSENSUS:
$38.50
UPSIDE:
68.86%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Wood | 1,985,547 | $46.4M | 0.1% | -2,896,506 | DECREASED |
| Cooperman | 1,601,896 | $37.4M | 0.0% | +382,287 | INCREASED |
| Greenblatt | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-07-08 | Metzger Michael A | director, officer: Chief Executive Officer | SELL | 32,375 | $24.24 | $785K |
| 2026-07-08 | Metzger Michael A | director, officer: Chief Executive Officer | M-Exempt | 32,375 | $6.38 | $207K |
| 2026-06-11 | Botwood Nicholas A.J. | officer: Head of R&D, CMO | M-Exempt | 22,515 | $13.82 | $311K |
| 2026-06-11 | Botwood Nicholas A.J. | officer: Head of R&D, CMO | SELL | 34,280 | $18.00 | $617K |
| 2026-06-12 | Botwood Nicholas A.J. | officer: Head of R&D, CMO | SELL | 31,235 | $18.14 | $567K |
| 2026-06-12 | Botwood Nicholas A.J. | officer: Head of R&D, CMO | M-Exempt | 31,235 | $13.82 | $432K |
| 2026-06-01 | Goldan Keith A. | officer: Chief Financial Officer | SELL | 1,177 | $18.99 | $22K |
| 2026-06-01 | Metzger Michael A | director, officer: Chief Executive Officer | SELL | 6,847 | $18.99 | $130K |
| 2026-02-09 | Goldan Keith A. | officer: Chief Financial Officer | SELL | 3,410 | $21.03 | $72K |
| 2026-02-09 | Metzger Michael A | director, officer: Chief Executive Officer | SELL | 17,159 | $21.03 | $361K |
| 2026-02-04 | Jarrett Jennifer | director | A-Award | 24,000 | -- | -- |
| 2026-02-04 | Metzger Michael A | director, officer: Chief Executive Officer | A-Award | 144,600 | -- | -- |
| 2026-02-04 | Goldan Keith A. | officer: Chief Financial Officer | A-Award | 30,750 | -- | -- |
| 2026-02-04 | Huber Martin H. Jr. | director | A-Award | 24,000 | -- | -- |
| 2026-02-04 | Katkin Keith | director | A-Award | 24,000 | -- | -- |
| 2026-02-04 | Legault Pierre | director | A-Award | 24,000 | -- | -- |
| 2026-02-06 | Goldan Keith A. | officer: Chief Financial Officer | SELL | 2,082 | $20.62 | $43K |
| 2026-02-04 | Goldan Keith A. | officer: Chief Financial Officer | A-Award | 21,500 | -- | -- |
| 2026-01-30 | Goldan Keith A. | officer: Chief Financial Officer | J-Other | 1,219 | $8.48 | $10K |
| 2026-02-06 | Metzger Michael A | director, officer: Chief Executive Officer | SELL | 7,412 | $20.62 | $153K |
| 2026-02-04 | Rizo Aleksandra | director | A-Award | 24,000 | -- | -- |
| 2026-02-04 | Botwood Nicholas A.J. | officer: Head of R&D, CMO | A-Award | 144,700 | $20.43 | $3.0M |
| 2026-02-04 | Podlesak Dennis | director | A-Award | 48,000 | -- | -- |
| 2026-02-04 | Metzger Michael A | director, officer: Chief Executive Officer | A-Award | 73,000 | -- | -- |
| 2026-02-04 | Botwood Nicholas A.J. | officer: Head of R&D, CMO | A-Award | 36,000 | -- | -- |